网站主页>>>研发精选>>>临床前CDMO研发筛选相关化合物
CDMO是Contract Development and Manufacturing Organization的缩写,即合同定制研发生产组织。它是一种为制药企业及生物技术公司提供医药(特别是创新药)工艺研发及制备、工艺优化、放大生产、注册和验证批生产以及商业化生产等定制服务的机构. 在传统代工基础上增加了研发和工艺优化能力,是高技术壁垒的工艺研发能力与规模生产能力的深度结合. 1, 工艺开发与优化:创新性合成路线设计、工艺参数优化. 2, 中试放大:实验室工艺向规模化生产的转化 3, 注册批生产:支持客户新药申报的验证批生产. 4, 商业化生产:药品上市后的大规模生产供应. 全球医药CDMO行业保持较高景气度。根据弗若斯特沙利文预测:2026年全球CDMO市场规模:预计达1,189亿美元 2033年全球CDMO市场规模:预计达3,385亿美元. CDMO作为医药产业链专业化分工的产物,已经从单纯的CMO代工模式升级为"研发+生产"一体化的高附加值服务。当前,在多肽、ADC、CGT等新型药物赛道的驱动下,全球及中国CDMO市场保持高速增长。中国CDMO企业凭借完整的供应链体系、工程师红利和一体化服务能力,全球市占率有望持续提升,行业正从"成本优势"竞争迈向"体系优势"竞争的新阶段。
如有产品调研服务, 请致函联系我们

客户展示

示例图片

临床前CDMO研发化合物筛选

  • Emodepside

    中文名称:艾默德斯
    CAS号:155030-63-0
    分子式: C60H90N6O14 分子量: 1119.39
    产品形式: Free Base
    研发状态: Not yet recruiting
    研发用途: Strongyloides Stercoralis Infection; Strongyloidiasis
    研究机构: Swiss Tropical & Public Health Institute; National Institute of Public Health Vientiane Laos
    研发日期: May 1 2024
    研发阶段: Phase 2
    Emodepside (QHT06, BAY 44-4400, PF 1022-221), a semisynthetic derivative of PF1022A, is a cyclooctadepsipeptide with broad-spectrum anthelmintic activity. Emodepside activates Ca-dependent SLO-1-like K channels.

  • Carmustine

    中文名称:卡莫司汀
    CAS号:154-93-8
    分子式: C5H9Cl2N3O2 分子量: 214.05
    产品形式: free base
    研发状态: Unknown status
    研发用途: Relapsed/Refractory Malignant Lymphomas
    研究机构: State Budgetary Healthcare Institution National Medical Surgical Center N.A. N.I. Pirogov Ministry of Health of Russia
    研发日期: January 22 2016
    研发阶段: Phase 2
    Carmustine (bis-chloroethylnitrosourea, BCNU, BiCNU) is a cell-cycle phase nonspecific alkylating antineoplastic agent and used in the treatment of brain tumors and various other malignant neoplasms.

  • Efavirenz

    中文名称: 依法韦仑
    CAS号:154598-52-4
    分子式: C14H9ClF3NO2 分子量: 315.67
    产品形式: free base
    研发状态: Terminated
    研发用途: Arthritis Rheumatoid; Interaction
    研究机构: University of Southern Denmark; Odense University Hospital; Hospital of South West Jutland; King Christian X´Hospital for Rheumatic Diseases; Sygehus Lillebaelt; Odense Patient Data Explorative Network
    研发日期: May 25 2021
    研发阶段: Phase 1 : Phase 2
    Efavirenz (Sustiva, Stocrin, DMP-266) is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral activity.

  • LY294002

    中文名称:2-吗啉代-8-苯基色酮
    CAS号:154447-36-6
    分子式: C19H17NO3 分子量: 307.34
    产品形式: free base
    研发状态: Terminated
    研发用途: Neuroblastoma
    研究机构: New Approaches to Neuroblastoma Therapy Consortium; SignalRX Pharmaceuticals Inc.; University of Southern California
    研发日期: July 9 2015
    研发阶段: Phase 1
    LY294002 (SF 1101, NSC 697286) is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation. It not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family. LY294002 also inhibits CK2 with IC50 of 98 nM. LY294002 is a non-specific DNA-PKcs inhibitor and activates autophagy and apoptosis.

  • Thioguanine (NSC 752)

    中文名称: 硫鸟嘌呤
    CAS号:154-42-7
    分子式: C5H5N5S 分子量: 167.19
    产品形式: free base
    研发状态: Unknown status
    研发用途: Lymphoblastic Leukemia Acute Childhood
    研究机构: Vastra Gotaland Region
    研发日期: Jan-17
    研发阶段: Phase 2
    Thioguanine (NSC 752, 6-Thioguanine, 2-Amino-6-purinethiol), a purine antimetabolite, inhibits DNMT1 activity through ubiquitin-targeted degradation, used in the treatment of acute lymphoblastic leukemia, autoimmune disorders (e.g., Crohn's disease, rheumatoid arthritis) and organ transplant recipients.

  • Capecitabine (RO 09-1978)

    中文名称:卡培他滨
    CAS号:154361-50-9
    分子式: C15H22FN3O6 分子量: 359.35
    产品形式: free base
    研发状态: Not yet recruiting
    研发用途: Breast Cancer
    研究机构: Novartis Pharmaceuticals; Novartis
    研发日期: May 16 2024
    研发阶段: Phase 1 : Phase 2
    Capecitabine (RO 09-1978) is a tumor-selective fluoropyrimidine carbamate, which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU. Capecitabine treatment of HCT-15 cells causes condensation of DNA and induces apoptosis.

  • 免费注册, 助力研发,生产, 销售.

    招募中心

    我们的宗旨: 净化, 简洁, 高效Purifying, concise, efficient !我们的口号: 减少中间商赚差价!

    即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.

    试运营阶段,所有广告业务5折优惠

    分类广告投放

    依据化学成分的不同, 针对不同的企业和产品, 我们提供分类产品广告投放.

    客户展示

    示例图片
    优秀企业推荐
    ×

    通知